tesamorelin ghk cu GHK-Cu 50mg tesamorelin and ghk cu GHK-CU

Although brain infarction volume reduction did not reach statistical significance, motor performance in the rotarod test significantly recovered in DSIP-treated animals compared to vehicle controls confirming a functionally relevant neuroprotective effect at the behavioural level and establishing intranasal delivery as a viable route for CNS DSIP research

Medications: Medication Interactions: There are some medicines which either stop proper absorption and metabolism of B vitamins

Inhaling high levels of certain substances can result in a metallic taste

Following the completion of these trials, the developer is expected to submit a New Drug Application (NDA) to the FDA in early 2027